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Abstract
Introduction
A 2012 systematic review and meta-analysis of randomized con-
trolled trials on emergency department–initiated tobacco control
(ETC) showed only short-term efficacy. The aim of this study was
to update data through May 2015.
Methods
After registering the study protocol on the international prospect-
ive register of systematic reviews (PROSPERO) in May 2015, we
searched 7 databases and the gray literature. Our outcome of in-
terest was the point prevalence of tobacco-use abstinence at 1-
month, 3-month, 6-month, or 12-month follow-up. We calculated
the relative risk (RR) of tobacco-use abstinence after ETC at each
follow-up  time  separately  for  each  study  and  then  pooled
Mantel–Haenszel  RRs  by  follow-up  time.  These  results  were
pooled with results of the 7 studies included in the previous re-
view. We calculated the effect of ETC on the combined point pre-
valence of tobacco-use abstinence across all follow-up times by
using generalized linear mixed models.
Results
We retrieved 4 additional studies, one published as an abstract,
comprising 1,392 participants overall.  The 1-month follow-up
point prevalence of tobacco-use abstinence after ETC resulted in
an RR of 1.49 (95% confidence interval [CI], 1.08–2.05) across 3
studies; 3-month follow-up, an RR of 1.38 (95% CI, 1.12–1.71)
across  9  studies;  6-month  follow-up,  an  RR of  1.09 (95% CI,
0.84–1.41) across 6 studies; and 12-month follow-up, an RR of
1.26 (95% CI, 1.00–1.59) across 3 studies. The effect on the com-
bined point prevalence of abstinence was an RR of 1.40 (95% CI,
1.06–1.86) (P = .02).
Conclusion
ETC is effective in promoting continual tobacco-use abstinence up
to 12 months after intervention. ETC may be a critically important
public health strategy for engaging hard-to-reach smokers in to-
bacco-use cessation.
Introduction
In 1998,  a  task force of  the Society for  Academic Emergency
Medicine published recommendations for screening and interven-
tion  activities  in  emergency  departments  (EDs),  including
smoking cessation counseling (1,2). In 2006, a panel convened by
the American College of Emergency Physicians called on emer-
gency care providers  to  routinely screen ED patients  for  their
smoking status and to initiate smoking cessation counseling or re-
ferral to outpatient treatment or both (3). These ED–initiated to-
bacco control (ETC) services are meant to reduce the burden of to-
bacco-related diseases by using the teachable moment of the ED
visit to motivate smokers to quit (3,4).
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Although several compelling arguments exist for such services, in-
cluding that the prevalence of smoking is high among ED patients
(5–7), typical ED patients are hard to reach, and EDs have high
levels of credibility on the topic of preventive and health promot-
ing services (8), the benefit of ETC is unclear.
A 2008 systematic review of smoking cessation interventions in
the ED (9) identified 7 studies; only one reported a significant in-
tervention benefit. Likewise, a systematic review and meta-analys-
is  that  was  published  in  2012  and  that  covered  publications
through October 2010 found a point-prevalence abstinence bene-
fit of ETC over usual care only at 1 month after ETC. That study
also found a nonsignificant effect (P = .08 across 7 studies) for a
cumulative point-prevalence abstinence benefit of ETC over all
follow-up points (1 month, 3 months, 6 months, and 12 months
after ETC) (10). In 2014, a systematic review identified 13 ran-
domized controlled trials (RCTs); 11 trials reported no significant
differences between study groups (11). Although persuasive evid-
ence exists on the efficacy of tobacco control interventions in oth-
er medical settings (12,13), the efficacy of ETC on cessation rates
for periods exceeding 1 month has yet to be demonstrated. The ob-
jective of our study was to provide an update of the systematic re-
view and meta-analysis of RCTs published in 2012 (10).
Methods
Data sources
This systematic review and meta-analysis updates a previous re-
view, which comprised 1,986 participants overall and included art-
icles published through October 4, 2010 (10). Inclusion criteria,
quality assessment, and analysis methods were identical to those
used in the previous review (10); all methods comply with the Pre-
ferred Reporting Items for Systematic Reviews and Meta-Ana-
lyses (PRISMA) statement (14). Details of our protocol were re-
gistered on the international prospective register of systematic re-
views  (PROSPERO)  in  May  2015  and  can  be  accessed  at
w w w . c r d . y o r k . a c . u k / P R O S P E R O / d i s p l a y _
record.asp?ID=CRD42015020581.
The systematic search was conducted by 1 reviewer (C.L.) in 7
electronic  databases:  MEDLINE,  The Cochrane Library,  EM-
BASE, PsycINFO, Scopus, LILACS (15), and the citation indexes
of the ISI Web of Knowledge. We screened the International Clin-
ical Trial Registry Platform for unpublished studies, the Confer-
ence Proceedings Citation Index, which contains information on
gray literature and unpublished studies, and the references of the
included studies to identify additional potentially relevant studies.
The following search terms were used: (Smok* AND Emergency
OR Tobacco AND Emergency OR Nicotine AND Emergency OR
Cigarette* AND Emergency) AND (Control OR Intervention* OR
Counseling OR Counselling OR Assistance OR Treat* OR Pre-
vention OR Promotion* OR Referral* OR Cessation) AND (ran-
domized OR randomly OR control* OR trial* OR controlled study
OR investigation OR prospective OR longitudinal OR pilot).
Study selection
We searched for studies published between October 4, 2010, and
May 15, 2015. Studies had to be accessible and published at least
as an abstract in English or Spanish. Inclusion criteria were RCTs
with ED patients of any age who were current smokers and who
were offered a tobacco control intervention. We defined smoking
cessation  interventions  according  to  the  American  College  of
Emergency Physicians statement (3) as motivational interviewing
or counseling on site in combination with referral to outpatient
treatments or to telephone quitlines. The treatment in the control
group could be usual care (receipt of brochures, self-help material,
information leaflets on state smokers’ quitlines, or any less intens-
ive program such as brief advice only or no material or advice at
all). The outcome — usually evaluated as self-reported 7 days of
tobacco-use abstinence (point-prevalence tobacco-use abstinence
[16]) — had to be measured at least once during follow-up.  We
excluded studies of patients from outpatient settings, studies of re-
latives or visitors of ED patients, and studies of hospitalized pa-
tients.
Relevant text was imported into Reference Manager Version 12.0
(Alfasoft GmbH). After duplicate removal, 2 reviewers (C.L. and
G.L.R.) independently screened titles and abstracts of all remain-
ing search results for relevance. In a second step, the full texts of
potentially relevant studies were assessed for eligibility. Any dis-
agreement between reviewers was resolved in discussion with a
third reviewer (B.N.).
Data extraction
Two investigators (C.L. and B.N.) extracted relevant information
on study design and outcomes independently. The following data
were extracted: 1) setting (type of ED, location, annual patient
census), 2) participants (total number in study, number in each
study arm, age and sex distribution), 3) smoking-related variables
(smoking definition, screening instruments, biologic validation,
and use of other biological markers [data not tabulated for this art-
icle]), 4) type of smoking cessation intervention and type of treat-
ment in the control group, 5) follow-up (time in months, number
of follow-up contacts, absolute number and percentage of parti-
cipants lost to follow-up, number of abstinent smokers [or other
outcomes] at each follow-up).
Risk of bias was assessed independently by two reviewers (C.L.
and B.N.) by employing the Quality Assessment Tool for Quantit-
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ative Studies (17). The tool includes ratings on the following 6
components: selection bias, study design, confounders, blinding,
data collection methods,  and withdrawals and dropouts.  Com-
bined  component  ratings  resulted  in  a  global  rating  of  either
“strong,” “moderate,” or “weak.” We assessed potential publica-
tion bias by constructing a funnel plot of the RRs that compared
the benefit of ETC with the control condition; the plot used data
from the longest follow-up point in each study. We used the Peters
test to evaluate the symmetry of the funnel plot (18).
Data synthesis
Although the number of follow-up contacts varied among studies,
all  studies  reported  abstinence  rates  at  1-month,  3-month,  6-
month, or 12-month follow-up. Study participants not reached at
follow-up were assumed to be current smokers. We calculated the
proportion of tobacco abstainers in both study arms for each study
for each follow-up time. The first  analysis across studies con-
sisted of pooling the relative risk (RR) of abstinence (which rep-
resents the relative benefit of the smoking cessation counseling (ie,
the ratios of the proportions of abstainers in the treatment group to
the proportions of abstainers in the control group) across studies
by using Mantel–Haenszel RRs. However, our main meta-analys-
is used the individual study results for each follow-up. To account
for heterogeneity among studies and repeated measurements with-
in studies, we used generalized linear mixed models (19,20) with
7-day point-prevalence tobacco-use abstinence at all follow-up
times as the outcome. We used random intercepts to model variab-
ility in smoking status across studies as a function of ETC treat-
ment versus no ETC treatment in interaction with time of assess-
ment. A log link and a binomial error distribution were used to es-
timate the log odds of RRs; exponentiation was then used to re-
port the RRs and their 95% confidence intervals (CIs). The vari-
ance–covariance matrix used reflected the fact that outcomes were
highly correlated across follow-up times within each study, be-
cause the repeated assessments of smoking behavior involved the
same participants. The final generalized linear mixed model was
set up with 4 fixed effects (the intercept, the treatment effect, the
effect of time, and their interaction). Additionally, we ran sensitiv-
ity analyses in subgroups, for example, involving studies that fea-
tured on-site motivational interviewing in combination with boost-
er telephone calls. P < .05 was defined as significant.
Results
The literature search initially identified 3,723 studies. Of these,
2,532 remained after duplicate removal. A further 2,504 studies
did not meet the inclusion criteria. Of the remaining 28 publica-
tions, 24 were excluded for other reasons (Figure 1), including 1
qualitative study and 2 quasi-RCTs (21–23).
Figure 1. Flowchart showing the literature search in 7 electronic databases
and the sequential study selection process. Abbreviations: ED, emergency
department; EMBASE, Excerpta Medica database; LILACS, Literatura Latino-
Americana  e  do  Caribe  em  Ciências  da  Saúde  (Literature  in  the  Health
Sciences in Latin America and the Caribbean); MEDLINE, MEDical Literature
Analysis and Retrieval System Online of the United States National Library of
Medicine;  PsycINFO,  literature  database  of  the  American  Psychological
Association; RCT, randomized controlled trial.
 
Four studies consisting of 1 abstract and 3 full-text articles and
comprising 1,392 participants were included in the systematic re-
view and meta-analysis (24–27). Follow-up time ranged from 1
month to 12 months.
Eligible studies
All 4 studies featured on-site motivational interviewing or cessa-
tion advice; 3 studies also featured booster telephone calls (Table
1). Anders et al (24) tested the feasibility and effectiveness of giv-
ing brief advice on site in combination with booster telephone
calls. An external telephone counseling service delivered these
calls within 2 weeks of the brief advice. Additionally, up to 6 cog-
nitive–behavioral therapy sessions, either telephone based or in
person, and nicotine replacement therapy (NRT) were provided
gratis. Control group participants received 1 session of personal-
ized cessation advice and printed self-help materials. Follow-up
occurred 3 months later. Both studies by Bernstein et al (25,26)
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tested a  combination of  on-site  motivational  interviewing and
booster telephone calls within 3 days. Additionally, study parti-
cipants were offered printed materials and NRT gratis for up to 6
weeks. The comparison group received a brochure and quitline in-
formation only. Biochemically confirmed tobacco-use abstinence
rate at 3 months was the primary end point. The second study by
Bernstein  et  al,  in  2015,  also evaluated abstinence rates  at  12
months (26). Cheung et al (27) explored a brief on-site interven-
tion followed by referral to a provincial telephone quitline; abstin-
ence rates were evaluated at 1-month, 3-month, 6-month, and 12-
month follow-up.
The proportion of abstinent smokers ranged from 4.9% to 34.6%
in the studies analyzed (Table 2). In 2 studies, smokers in the in-
tervention group had higher abstinence rates than did smokers in
the control group (25,26). Anders et al (24) demonstrated that all
participants in the intervention group consented to a faxed referral,
of whom 13.5% attended treatment sessions, whereas 2.7% of the
control group attended treatment sessions. Cheung et al (27) found
that 16 of 27 (59.3%) participants in the intervention group accep-
ted a referral to the quitline; 6 participants were reached, but only
5 enrolled in the program and only 2 completed the program.
Risk of bias assessment
When we used the Quality Assessment Tool for Quantitative Stud-
ies to assess the risk of bias associated with the 3 full-text studies,
2 studies received a moderate rating (24,26), and 1 study received
a weak rating (25). The study by Cheung et al (27) could not be
assessed because of insufficient information.
Update of the systematic review and meta-analysis
When we added the evidence from the newly retrieved studies to
the evidence from the previous meta-analysis (10), we found that
pooled results at 1 month after ETC (P = .01) and at 3 months after
ETC (P = .003) were significant (Table 3). At 12 month follow-up,
the pooled results were not significant (P = .05). Pooling all avail-
able evidence from all follow-up assessments across 11 studies,
the cumulative point-prevalence abstinence of ETC compared with
the control condition yielded an RR of 1.40 (95% CI, 1.06–1.86)
(P = .02). Excluding the study by Cheung et al, which was repor-
ted as an abstract only, the cumulative point-prevalence abstin-
ence of ETC compared with the control condition yielded an RR
of 1.36 (95% CI, 1.00–1.85) (P = .047). Pooling the 8 studies that
evaluated on-site motivational interviewing compared with boost-
er telephone calls (24–26,30–34), yielded an RR of 1.39 (95% CI,
1.00–1.92) (P = .048). Further sensitivity analyses showed that
after pooling only the 4 newly retrieved studies, the cumulative
point-prevalence abstinence of ETC compared with the control
condition yielded an RR of 1.57 (95% CI, 0.59–4.17) (P = .24).
Pooling the 4 studies with biochemically confirmed smoking out-
comes (25,26,32,34), the cumulative point-prevalence abstinence
of ETC compared with the control condition yielded an RR of
1.34 (95% CI, 0.91–1.97) (P = .10).
The funnel plot, based on 11 observations, was not significantly
asymmetric (t11 = −0.57, P = .58) (Figure 2). Overall, 7 studies had
positive results (RR > 1), some of which had large standard devi-
ations; however, the 4 studies with negative results (RR < 1) show
both large and small standard deviations.
Figure 2. Funnel plot showing the effect estimates (Mantel-Haenszel relative
risks/benefits of emergency department–initiated tobacco control) on the x-
axis and the standard errors of the effect estimates on the y-axis. The funnel
plot used data from the final follow-up observation in 11 studies. Both axes
are log-10 scales.
 
Discussion
This update of a systematic review and meta-analysis of RCTs
evaluating the efficacy of ETC indicated an overall benefit of ETC
over the control condition on repeated 7-day point-prevalence ab-
stinence at 1-month, 3-month, 6-month, and 12-month follow-up.
At 1-month and 3-month follow-up, the pooled 7-day point-pre-
valence abstinence was higher in the ETC group than in the con-
trol group and showed a tendency to be higher at 12-month fol-
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low-up. Eight (24–26,30–34) of 11 studies evaluated interven-
tions that combined on-site motivational interviewing with boost-
er telephone calls. Pooling these studies, ETC showed higher cu-
mulatively assessed point-prevalence abstinence than did the con-
trol condition.
The quality standard of our systematic review was similar to that
of Rabe et al (10): our literature search encompassed the 7 most
relevant major electronic databases and unpublished studies. We
documented the methodological quality and the risk of bias for all
11 studies included in our review. The statistical approach replic-
ated that used in our earlier systematic review. We conservatively
assumed that all participants lost to follow-up were smoking at
follow-up.  We  found  some  heterogeneity  in  the  intervention
strategies used in the studies. However, all but 1 of the newly re-
trieved studies and 8 of the 11 studies in the review investigated
the impact of the combination of motivational interviewing and
advice to quit on site or through booster telephone calls delivered
promptly after the ED treatment. In 3 of 4 of the newly retrieved
studies,  study participants received NRT gratis.  Heterogeneity
mainly occurred in the provision of self-help materials and bro-
chures  and referrals  to  telephone quitlines.  Our  statistical  ap-
proach accounted for this heterogeneity in the calculation of the
overall effect of ETC. Our approach allowed for between-study
variance and within-study variance over time and may therefore
satisfactorily reflect the true variability of intervention conditions
in clinical practice. The funnel plot showed that 4 (of 11) studies
with negative results were indeed published, although 7 (of 11)
studies had positive results.  The overall  shape of the plot  was
fairly symmetric (with predictably greater heterogeneity of effect
sizes among the smaller studies, as reflected in the expected inver-
ted funnel shape [35]). This lack of funnel plot asymmetry was
confirmed statistically. Despite the foregoing, publication bias
cannot be ruled out as the explanation for these data, but it seems
unlikely. Pooling results of the newly retrieved studies showed an
effect size larger than that found by the previous meta-analysis
(10). Thus, the more impressively significant results of the current
update are attributable to both the increased cumulative sample
size made possible by the addition of the newly retrieved studies
and to the larger effect sizes reported by these recent studies. Ab-
stinence rates at 6 months and 12 months in the newly retrieved
studies with larger sample sizes compared favorably with the res-
ults of the previous meta-analysis (10). One possible reason for
this improvement is the more consistent delivery of NRT in the
more recent trials. Not all studies validated smoking outcomes
biologically. The pooled result on the cumulative point-preval-
ence abstinence of ETC in studies with validated tobacco abstin-
ence was slightly weaker (RR = 1.34) than the pooled result of all
available studies (RR = 1.40). Although several studies that ex-
amined the validity of self-reported smoking data concluded that
self-reported smoking history was accurate (36,37), our finding
may indicate some social  desirability bias in the nonvalidated
studies and thus may slightly overestimate the true effect of ETC.
From a public health point-of-view, a measure of continuous to-
bacco-use abstinence would provide more unambiguous evidence
of long-term ETC efficacy than the measure of point-prevalence
abstinence used here (13,15). However, insisting on strictly con-
tinuous abstinence may unfairly classify too many successes as re-
lapses (15,38).  It  is  common research practice to assess 7-day
point-prevalence rates supported by a negative biochemical test
(15), because these data are regarded as valid, replicable outcome
measures and less likely to be biased by faulty recall or social de-
sirability.
This meta-analysis  showed a nonmonotonic attenuation of the
ETC effect over 12 months. We believe that the apparent drop in
effect size at 6 months was artifactual and does not represent the
12-month  trend.  Of  6  studies  pooled  at  6  months,  3  studies
(27,28,30) showed negative results. Two of these studies (28,30)
reported no 12-month results. The third study (27) found an ad-
vantage  of  ETC over  the  control  condition  at  1  month  and  3
months but not thereafter. Thus, the attenuation at 6 months was
driven by 2 studies with 6-months–only results and by 1 small
study, which attenuated the pooled 12-month results negligibly.
However, a drop-off of intervention effect over time is character-
istic of most interventions designed to reduce psychoactive drug
use (39) or tobacco use (38). Without changing the conditions that
gave rise to smoking in the first place, relapse appears to be the
rule. Even if tobacco abstinence is time-limited, there is nonethe-
less a significant benefit to the smoker’s lung health in having en-
joyed a respite from smoking’s daily assault on normal physiolo-
gical functioning (40). Moreover, previous experience with quit-
ting seems to predispose to further attempts to quit (38).
Our review and meta-analysis strengthen and extend the evidence
for the beneficial impact of smoking cessation interventions in
EDs. The addition of the most recent studies has enriched the port-
folio of novel approaches, especially booster sessions after the ini-
tial contact in the ED. Anders et al (24) used cessation services
that offered 2 telephone calls within 2 weeks after ED treatment. A
similar approach was chosen by Cheung et al (27) and Bernstein et
al (25,26), who referred patients to a telephone quitline service.
Such services have shown their feasibility and effectiveness in to-
bacco control in other settings, such as primary care practices (41).
The use of telephone quitline services might reduce the workload
of EDs that do not have such follow-up services available. Anders
et al (24) and Bernstein et al (25,26) provided NRT gratis to their
patients. Participants with higher levels of nicotine dependence
were less likely to benefit from exposure to tobacco counseling in
EDs or other settings (34,42–44). Additionally, providing NRT
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during cessation counseling (alone or in combination with other
pharmacologic strategies) increased the number of quit attempts
and abstinence rates in certain patient groups (45,46). Because we
had no individual data and thus no information on the actual use of
NRT in  the  populations  studied in  this  systematic  review and
meta-analysis, we could not identify the attributable benefit of
NRT provided gratis  on near-term or long-term cessation out-
comes.
Our meta-analysis suggests that cessation counseling initiated in
the ED promotes repeated tobacco abstinence. Because of their
high levels of reach and the high percentage of ED patients who
smoke, EDs may play an important population-level role in motiv-
ating patients to quit smoking (3). EDs are especially important
venues for reaching young and uninsured people, who appear dis-
proportionately in EDs. The level of credibility of ED staff mem-
bers in prevention and health promotion is high, and the teachable
moment offered by an ED-based intervention is a persuasive argu-
ment for supporting such services (47). The core curriculum of
emergency medicine now incorporates knowledge on tobacco epi-
demiology and motivational interviewing techniques as outlined in
the joint statement of emergency medicine organizations in 2006
(3). Acknowledgment of the role of EDs in promoting preventive
and health-promoting services is changing, and ED staff members
readily accept that ED encounters may provide a teachable mo-
ment for encouraging smoking cessation (22,23).  More know-
ledge is needed on how to incorporate ETC into clinical routine ef-
ficiently. Implementation of a multifaceted smoking cessation in-
tervention in an ED can be facilitated by context-specific training,
a systematic approach to assessment and action,  and reminder
tools (21,23,48). Routine use of computerized decision-support
systems helped nurses and physicians to implement tobacco cessa-
tion treatment and further referral in a pediatric ED (49). In the
clinical setting, a best-practice alert that appeared when patients
were coded as smokers in the electronic health record motivated
physicians to order tobacco-cessation treatment medication and to
refer their patients to a telephone quitline (50). Such devices and
approaches may help to further integrate tobacco control services
in EDs into clinical routine.
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Tables
Table 1. Characteristics of the 4 Studies Retrieved by a Systematic Review of Studies Describing Emergency Department–Initiated Tobacco Controla
Study Characteristic
Anders et al, United
States, 2011b
Bernstein et al, United States,
2011c
Cheung et al, Canada,
2013d
Bernstein et al, United
States, 2015e
No. of participants randomized
(intervention/ control) [target group]
221 (111/110) [Adults] 338 (170/168) [Adults] 53 (27/26) [Adults] 778 (388/390) [Adults]
Setting (estimated no. of patients
annually)
Urban emergency
department (48,000)
Urban emergency department
(90,000)
Urban emergency
department (85,000)
Urban emergency
department (90,000)
Smoking definition Answer of yes to the
question “Do you smoke
tobacco?” and smokes ≥1
cigarette per day
Smoked >100 cigarettes in
lifetime and current daily or
occasional smokers with a mean
consumption of ≥10 cigarettes
per day
Tobacco use within the
previous 30 days
Smoked >100 cigarettes in
lifetime and current or
occasional smokers with a
mean consumption of >5
cigarettes per day
Treatment in the intervention group
Advice and/or motivational interviewing on
site
Yes Yes Yes Yes
Booster telephone calls Yes Yes No Yes
Free nicotine replacement therapy Yes Yes No Yes
Brochure No Yes No Yes
Treatment in the control group 1) Personalized advice to
quit smoking given by an
advanced practice nurse
and 2) self-help material
plus brochure with
contact information for
cessation a program
Brochure with general
information about smoking
cessation and contact
information for smoking
cessation programs
Usual practice only 1) Brochure with general
information about smoking
cessation and 2) telephone
number of the state smokers’
quitline
Definition of tobacco-use abstinence Self-reported 7 days of
abstinence
Self-reported 7 days of
abstinence, verified by exhaled
carbon monoxide and salivary
cotinine
30-day point-prevalence
abstinence
Self-reported 7 days of
abstinence, verified by
exhaled carbon monoxide
a This systematic review and meta-analysis updates a previous review (10) and includes publications published between October 4, 2010, and May 15, 2015.
b Anders et al (24).
c Bernstein et al (25).
d Cheung et al (27).
e Bernstein et al (26).
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Table 2. Number and Proportion of Abstinent Smokers at Follow-Up in 4 Studies Retrieved By a Systematic Review of Studies Describing Emergency
Department–Initiated Tobacco Controla
Study (Year of
Publication) Type of Group
No. of Randomized
Participants
No. (%) Abstinent Smokers at Follow-Upb
1 Month 3 Months 6 Months 12 Months
Anders et al (2011)c Intervention 111  — 5 (4.5)  —  —
Control 110  — 8 (7.3)  —  —
Bernstein et al
(2011)d
Intervention 170  — 25 (14.7)  —  —
Control 168  — 22 (13.2)  —  —
Cheung et al (2013)e Intervention 27 7 (25.9) 8 (29.6) 6 (22.2) 4 (14.8)
Control 26 4 (15.4) 4 (15.4) 9 (34.6) 7 (26.9)
Bernstein et al
(2015)f
Intervention 388  — 47 (12.1)  — 62 (16.0)
Control 390  — 19 (4.9)  — 45 (11.5)
a This systematic review and meta-analysis updates a previous review (10) and includes publications published between October 4, 2010, and May 15, 2015.
b Dashes indicate that study did not collect follow-up data at that point.
c Anders et al (24).
d Bernstein et al (25).
e Cheung et al (27).
f Bernstein et al (26).
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Table 3. Benefit of Emergency Department-Initiated Tobacco Control Compared With Control Condition on Tobacco-Use Results of Individual Studies (N = 11) and
Meta-Analyses, by Follow-Up Timea
Year of Publication, Study
Mantel–Haenszel Relative Risk (95% Confidence Interval)
1 month 3 months 6 months 12 months
2000, Antonacci and Eyck (28) — — 0.33 (0.01–7.74)b —
2000, Richman et al (29) — 1.14 (0.36–3.57) — —
2007, Horn et al (30) — — 0.83 (0.05–12.77) —
2007, Schiebel and Ebbert (31) — 2.00 (0.20–20.33) 9.00 (0.52–156.91)b —
2008, Bock et al (32) 1.64 (1.04–2.56) 1.35 (0.86–2.12) 1.04 (0.64–1.68) —
2008, Boudreaux et al (33) — 1.86 (0.25–13.91) — —
2009, Neuner et al (34) 1.30 (0.79−2.15) 1.13 (0.75–1.69) 1.14 (0.81–1.61) 1.25 (0.91–1.72)
2011, Anders et al (24) — 0.62 (0.21–1.83) — —
2011, Bernstein et al (25) — 1.12 (0.66–1.91) — —
2013, Cheung et al (27) 1.69 (0.56–5.08) 1.93 (0.66–5.63) 0.64 (0.27–1.55) 0.55 (0.18–1.66)
2015, Bernstein et al (26) — 2.49 (1.49–4.16) — 1.38 (0.97–1.98)
Meta analyses 1.49 (1.08–2.05) [P = .01] 1.38 (1.12–1.71) [P = .003] 1.09 (0.84−1.41) [P = .54] 1.26 (1.00–1.59) [P = .05]
a This systematic review and meta-analysis updates a previous review (10) and includes publications published between October 4, 2010, and May 15, 2015.
b 0.5 added to all cells of the 2 × 2 table in calculating the relative risks to avoid degeneracy caused by sampling zero counts.
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